BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30325236)

  • 1. Expression of programmed death-1 (PD-1) and its ligand PD-L1 is upregulated in endometriosis and promoted by 17beta-estradiol.
    Wu L; Lv C; Su Y; Li C; Zhang H; Zhao X; Li M
    Gynecol Endocrinol; 2019 Mar; 35(3):251-256. PubMed ID: 30325236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal status influences the expression of programmed death (PD)-1 and its ligand PD-L1 on immune cells from the human female reproductive tract.
    Shen Z; Rodriguez-Garcia M; Patel MV; Barr FD; Wira CR
    Am J Reprod Immunol; 2016 Aug; 76(2):118-25. PubMed ID: 27321759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer.
    Nero C; Romito I; Spadola S; Romito A; Turco LC; Cosentino F; De Ninno M; Catena U; De Cicco Nardone A; Moroni R; Zannoni G; Fagotti A; Scambia G
    Fertil Steril; 2022 Jan; 117(1):160-168. PubMed ID: 34656305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1-expressing B cells suppress CD4
    Wang X; Wang G; Wang Z; Liu B; Han N; Li J; Lu C; Liu X; Zhang Q; Yang Q; Wang G
    Mol Immunol; 2019 May; 109():20-26. PubMed ID: 30851633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warming Menstruation and Analgesic Soup Inhibits PD-1/PD-L1 Pathway in Rats with Endometriosis.
    Feng D; Wang X; Huang Y; Chen X; Xu R; Qu Z; Chou D
    Altern Ther Health Med; 2023 May; 29(4):152-157. PubMed ID: 36933247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression.
    Saito H; Kono Y; Murakami Y; Shishido Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
    Anticancer Res; 2018 Jan; 38(1):107-112. PubMed ID: 29277762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol.
    Zeitoun K; Takayama K; Sasano H; Suzuki T; Moghrabi N; Andersson S; Johns A; Meng L; Putman M; Carr B; Bulun SE
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4474-80. PubMed ID: 9851796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1/PD-L Pathway Potentially Involved in ITP Immunopathogenesis.
    Nie M; Liu Y; Li XX; Min YN; Yang DD; Li Q; Feng Q; Hou Y; Li GS; Sun JZ; Hou M; Shi Y
    Thromb Haemost; 2019 May; 119(5):758-765. PubMed ID: 30808044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Value of the PD-1/PD-L1/PD-L2 Pathway in Patients Suffering from Endometriosis.
    Suszczyk D; Skiba W; Zardzewiały W; Pawłowska A; Włodarczyk K; Polak G; Tarkowski R; Wertel I
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced PD-L1/PD-1 crosstalk impairs T-cell function in sleep apnoea.
    Cubillos-Zapata C; Avendaño-Ortiz J; Hernandez-Jimenez E; Toledano V; Casas-Martin J; Varela-Serrano A; Torres M; Almendros I; Casitas R; Fernández-Navarro I; Garcia-Sanchez A; Aguirre LA; Farre R; López-Collazo E; García-Rio F
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29051270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity.
    Braun NA; Celada LJ; Herazo-Maya JD; Abraham S; Shaginurova G; Sevin CM; Grutters J; Culver DA; Dworski R; Sheller J; Massion PP; Polosukhin VV; Johnson JE; Kaminski N; Wilkes DS; Oswald-Richter KA; Drake WP
    Am J Respir Crit Care Med; 2014 Sep; 190(5):560-71. PubMed ID: 25073001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between programmed cell death ligand-1 expression and extracranial metastasis in intracranial solitary fibrous tumor/hemangiopericytoma.
    Kamamoto D; Ohara K; Kitamura Y; Yoshida K; Kawakami Y; Sasaki H
    J Neurooncol; 2018 Sep; 139(2):251-259. PubMed ID: 29675794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranscriptional Control of PD-L1 Expression by 17β-Estradiol via PI3K/Akt Signaling Pathway in ERα-Positive Cancer Cell Lines.
    Yang L; Huang F; Mei J; Wang X; Zhang Q; Wang H; Xi M; You Z
    Int J Gynecol Cancer; 2017 Feb; 27(2):196-205. PubMed ID: 27870715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distribution and Clinical Significance of CTLA-4, PD-1 and PD-L1 in Peripheral Blood of Patients with Small Cell Lung Cancer].
    Li H; Liu Y; Liu Y; Liu J; Zhao D; Wang Y; Cheng Y
    Zhongguo Fei Ai Za Zhi; 2017 Nov; 20(11):755-760. PubMed ID: 29167005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell Carcinoma.
    Schoenfeld JD; Gjini E; Rodig SJ; Tishler RB; Rawal B; Catalano PJ; Uppaluri R; Haddad RI; Hanna GJ; Chau NG; Rabinowits G; Lorch J; Jo VY; Krane JF; Goguen LA; Annino DJ; Abdelrahman S; Lipschitz M; Margalit DN
    Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):137-145. PubMed ID: 29960819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of steroid hormone on estrogen sulfotransferase and on steroid sulfatase expression in endometriosis tissue and stromal cells.
    Piccinato CA; Neme RM; Torres N; Sanches LR; Derogis PBMC; Brudniewski HF; Rosa E Silva JC; Ferriani RA
    J Steroid Biochem Mol Biol; 2016 Apr; 158():117-126. PubMed ID: 26723541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
    Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
    Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo effect of PD-1/PD-L1 blockade on microglia/macrophage activation and T cell subset balance in cryptococcal meningitis.
    Che YM; Zhang Y; Li M; Li XP; Zhang LL
    J Cell Biochem; 2018 Apr; 119(4):3044-3057. PubMed ID: 29058791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Increase of Circulating PD-1- and PD-L1-Expressing Lymphocytes in Endometriosis: Correlation with Clinical and Laboratory Parameters.
    Walankiewicz M; Grywalska E; Polak G; Korona-Glowniak I; Witt E; Surdacka A; Kotarski J; Rolinski J
    Mediators Inflamm; 2018; 2018():7041342. PubMed ID: 30595667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial Stromal PD-L1 (Programmed Death Ligand 1) Modulates CD8
    Bracamonte-Baran W; Gilotra NA; Won T; Rodriguez KM; Talor MV; Oh BC; Griffin J; Wittstein I; Sharma K; Skinner J; Johns RA; Russell SD; Anders RA; Zhu Q; Halushka MK; Brandacher G; Čiháková D
    Circ Heart Fail; 2021 Oct; 14(10):e007982. PubMed ID: 34555935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.